Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway
Maozhang Li, Guangwei Bai, Yi Cen, Qitong Xie, Jiahong Chen, Jia Chen, Qingbiao Chen, Weide Zhong, Xiaobo Zhou · 2023
Read Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway by Maozhang Li, Guangwei Bai, Yi Cen, Qitong Xie, Jiahong Chen, Jia Chen, Qingbiao Chen, Weide Zhong, Xiaobo Zhou (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10701956.txt.
Description
Li and eight co-authors show that switching off a gene called HOXC13 can slow prostate cancer growth, in a study from twenty twenty-three. Advanced prostate cancer often resists hormone therapy and spreads. A small set of gene switches drives that resistant form. The team hunted for the key switch among twenty-five candidates.
HOXC13 stood out with the worst outlook for patients who had high levels. Tumor tissue held far more of it than healthy tissue. Silencing it in cancer cells caused DNA damage and woke an immune alarm path. It also shifted which immune cells enter tumors. Silenced cells made more immune signal molecules. The gene looks like a strong target for new prostate cancer drugs.
Catalog record
| CREATOR | Maozhang Li, Guangwei Bai, Yi Cen, Qitong Xie, Jiahong Chen, Jia Chen, Qingbiao Chen, Weide Zhong, Xiaobo Zhou |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |